Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL824434 | 0.77 | ALDH1A1 (0.56) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL13658055 | 0.68 | KDM4E (0.43) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL11829105 | 0.66 | ALDH1A1 (0.62) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL17265813 | 0.64 | ALDH1A1 (0.60) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL4549616 | 0.64 | ALDH1A1 (0.42) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL14845583 | 0.60 | PIK3CG (0.39) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL28993205 | 0.58 | KDM4E (0.52) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL2131090 | 0.55 | KDM4E (1.00) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL19153128 | 0.55 | ALDH1A1 (0.44) | KDM4EALDH1A1GLAGAAHPGD | |
| SCHEMBL14104382 | 0.54 | HPGD (0.47) | KDM4EALDH1A1GLAGAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8416376-B2 | Compensated in-plane switching mode liquid crystal display | CRYSOPTIX KK (JP) | 2013-04-09 | — | — | US | disclosed |
| US-8142863-B2 | Color liquid crystal display and compensation panel | Crysoptix, KK (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20100279122-A1 | Benzimidazole, Benzoxazole and Benzothiazole Derivatives, Optical Film Comprising them and Method of Producing thereof | CRYSOPTIX KK (JP) | 2010-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100279122-A1 | Benzimidazole, Benzoxazole and Benzothiazole Derivatives, Optical Film Comprising them and Method of Producing thereof | BMX, ABCG2, BRI3BP | KDM4E 1712/4885ALDH1A1 1696/4885GLA 3398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.